Assessing the efficacy of RNA polymerase II- and RNA polymerase III promoter-driven RNA interference effecter cassettes targeted to HBx
Globally, the status of chronic infection with hepatitis B virus (HBV) is increasing, with approximately twenty million new cases being reported each year. Chronically infected individuals are at risk of developing complications of cirrhosis and hepatocellular carcinomas. Currently, treatment of HBV...
| Main Author: | |
|---|---|
| Format: | Others |
| Language: | en |
| Published: |
2010
|
| Online Access: | http://hdl.handle.net/10539/8567 |